The Mosaic Company
MOS
$24.76
-2.02%
The Mosaic Company is a leading global producer and marketer of concentrated phosphate and potash crop nutrients, operating within the Agricultural Inputs industry. The company is a major player in the global fertilizer market, with integrated phosphate rock mines in the United States and potash mines in Canada, complemented by a significant fertilizer distribution network in Brazil through its Mosaic Fertilizantes business. The current investor narrative is heavily focused on the volatile supply-demand dynamics of the fertilizer market, with recent attention driven by geopolitical events such as the closure of the Strait of Hormuz, which has the potential to create significant margin opportunities for North American producers like Mosaic that possess local input sources, against a backdrop of cyclical pressures on pricing and demand.…
MOS
The Mosaic Company
$24.76
MOS 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on The Mosaic Company's 12-month outlook, with a consensus price target around $32.19 and implied upside of +30.0% versus the current price.
Average Target
$32.19
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$20 - $32
Analyst target range
Analyst coverage is limited, with only 5 analysts providing estimates, indicating this is a less-followed name which can lead to higher volatility and less efficient price discovery. The average revenue estimate for the coming period is $11.9 billion, with a wide range from $10.3 billion to $13.6 billion, and the average EPS estimate is $2.04, ranging from $1.69 to $2.42, highlighting significant uncertainty in forward projections. Recent institutional rating actions show a clear trend of downgrades and cautious positioning, including moves from Buy to Neutral by B of A Securities and from Overweight to Equal Weight by Barclays in early 2026, signaling a deteriorating near-term sentiment among professional analysts.
Bulls vs Bears: MOS Investment Factors
The evidence currently favors the bear case, given the concrete deterioration in fundamentals—negative free cash flow, compressing margins, and declining revenue—against a backdrop of severe technical underperformance and analyst downgrades. The primary tension in the investment debate is the timing and magnitude of a cyclical recovery in fertilizer prices and demand. The bullish thesis hinges on deep-value multiples and a geopolitical supply shock catalyzing that recovery, while the bearish thesis warns of prolonged margin pressure and cash burn if the downturn persists. The resolution of this cycle timing is the single most important factor that will determine the stock's direction.
Bullish
- Deep Value Multiples: MOS trades at a significant discount to its sector based on a P/S of 0.63x and P/B of 0.63x. Its forward P/E of 10.1x is also low, implying the market has priced in a pessimistic earnings scenario, leaving room for multiple expansion if fundamentals improve.
- Geopolitical Supply Tailwind: Recent news highlights the closure of the Strait of Hormuz, which has stranded a third of global fertilizer supply. As a North American producer with local phosphate and potash mines, MOS is positioned to capture margin opportunities from supply disruptions.
- Analyst EPS Recovery Expected: Analysts project a significant earnings recovery, with average forward EPS of $2.04, up sharply from the trailing EPS of $0.07. This implies a forward P/E of 10.1x, suggesting the stock is cheap if these estimates are met.
- Strong Balance Sheet: The company maintains moderate leverage with a debt-to-equity ratio of 0.44 and adequate liquidity with a current ratio of 1.32. This financial stability provides a buffer against the cyclical downturn and funds operations despite negative free cash flow.
Bearish
- Severe Profitability Compression: Profitability has deteriorated sharply, with Q4 2025 net margin at 6.2%, down from 13.7% in Q2 2025. Gross margin also fell to 14.2% from 17.3% over the same period, indicating significant pricing pressure and cost challenges.
- Persistent Negative Free Cash Flow: The company's trailing twelve-month free cash flow is deeply negative at -$535 million. This cash burn raises concerns about its ability to fund operations, maintain its dividend, and invest without increasing leverage, especially in a downcycle.
- Revenue Decline & Weak Momentum: Q4 2025 revenue declined -7.6% year-over-year, reflecting weakening demand. The stock's severe underperformance, down -18.4% over six months and -27.2 in relative strength vs. the S&P 500, confirms persistent negative momentum and investor skepticism.
- Analyst Downgrades & Low Coverage: Recent institutional actions include downgrades from Buy to Neutral and Overweight to Equal Weight in early 2026. With only 5 analysts covering the stock, sentiment is poor and price discovery is less efficient, contributing to volatility.
MOS Technical Analysis
The stock is in a pronounced downtrend, evidenced by a 1-year price change of only +2.3%, which significantly underperforms the S&P 500's +29.5% gain, and a more severe 6-month decline of -18.4%. Currently trading at $24.76, the price sits at just 15% of its 52-week range ($23.06 to $38.23), indicating it is near multi-year lows, which may represent a deep value opportunity but also signals persistent negative momentum and investor pessimism. Recent momentum remains weak, with the stock down -15.1% over the past month and -4.7% over the past three months, a continuation of the longer-term downtrend rather than a divergence. The stock's beta of 0.96 suggests its volatility is roughly in line with the broader market, but its severe underperformance, highlighted by a -27.2 relative strength figure over one year, points to significant company-specific or sector-specific headwinds. Key technical support is clearly defined at the 52-week low of $23.06, while resistance lies at the 52-week high of $38.23; a sustained breakdown below $23 could trigger further selling, whereas a recovery above the recent high near $31.36 from March would be needed to signal a potential trend reversal.
Beta
0.96
0.96x market volatility
Max Drawdown
-38.0%
Largest decline past year
52-Week Range
$23-$38
Price range past year
Annual Return
+2.3%
Cumulative gain past year
| Period | MOS Return | S&P 500 |
|---|---|---|
| 1m | -15.1% | +2.6% |
| 3m | -4.7% | -2.3% |
| 6m | -18.4% | +2.6% |
| 1y | +2.3% | +27.3% |
| ytd | -1.0% | -0.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MOS Fundamental Analysis
Revenue growth has been inconsistent and recently negative, with Q4 2025 revenue of $2.60 billion representing a -7.6% year-over-year decline, continuing a trend of deceleration from stronger growth in earlier quarters of 2025. Segment data from the latest period shows Mosaic Fertilizantes as the largest contributor at $1.15 billion, followed by Phosphates at $1.01 billion and Potash at $681 million, indicating diversified but pressured end markets. The company remains profitable, with Q4 2025 net income of $162 million, translating to a net margin of 6.2%, but profitability has compressed significantly from the 13.7% net margin seen in Q2 2025, reflecting margin pressure. Gross margin for Q4 2025 was 14.2%, down from 17.3% in Q2 2025, indicating cost pressures or pricing declines, while the trailing twelve-month free cash flow is deeply negative at -$535 million, raising concerns about internal funding capacity. The balance sheet shows moderate leverage with a debt-to-equity ratio of 0.44 and adequate liquidity with a current ratio of 1.32, but the negative free cash flow and a return on equity of just 4.5% suggest challenges in generating efficient returns on capital in the current cycle.
Quarterly Revenue
$2.6B
2025-12
Revenue YoY Growth
-0.07%
YoY Comparison
Gross Margin
+0.14%
Latest Quarter
Free Cash Flow
$-534600000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MOS Overvalued?
Given a positive net income, the primary valuation metric is the P/E ratio. The trailing P/E is 14.1x, while the forward P/E is notably lower at 10.1x, based on estimated EPS of $2.04; this forward discount implies the market expects earnings to recover from the depressed trailing figure of $0.07. Compared to sector averages, Mosaic trades at a significant discount based on its P/S ratio of 0.63x and P/B ratio of 0.63x, which are well below typical commodity producer multiples, reflecting skepticism about the sustainability of its earnings and cash flow. Historically, the stock's current trailing P/E of 14.1x is below its own multi-year range, which has seen peaks above 57x during trough earnings periods and lows in single digits during high-profitability cycles, suggesting the current valuation prices in a mid-cycle or slightly pessimistic scenario, but not extreme distress.
PE
14.1x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -702x~58x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
4.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced. The company is burning cash at a rate of -$535 million TTM, which threatens its dividend (payout ratio of 52%) and capital flexibility if sustained. Profitability is volatile, with net margin compressing from 13.7% to 6.2% in just two quarters, and return on equity is a weak 4.5%, indicating poor capital efficiency. While leverage is moderate at a D/E of 0.44, the negative FCF increases reliance on external financing or balance sheet drawdowns.
Market & Competitive Risks center on its cyclical nature and valuation. The stock trades at a deep discount (P/S 0.63x) because the market anticipates further earnings deterioration; a failure to recover could lead to permanent value impairment. Its beta of 0.96 indicates market-correlated moves, but its -27.2 relative strength shows severe company-specific headwinds. The recent geopolitical news is a double-edged sword—while a potential catalyst, it also highlights the commodity-like, event-driven volatility of the business model, where prices are set globally.
Worst-Case Scenario involves a prolonged global fertilizer glut, exacerbated by a recessionary drop in agricultural demand, leading to sustained pricing pressure. This would force further margin compression, potentially pushing net income negative, jeopardizing the dividend, and requiring asset sales or equity raises. The realistic downside is to the 52-week low of $23.06, representing a -7% decline from the current price. However, in a severe cyclical trough akin to past drawdowns (max drawdown -38%), the stock could re-test levels near $20, implying a potential loss of -19% to -25% from current levels.